STCube

STCube Days Inventory Outstanding

The Days Inventory Outstanding (DIO) of STCube (052020.KQ) as of Oct 24, 2026 is 75.29. In the previous year, Days Inventory Outstanding (DIO) was 52.02 — a change of 44.74% (higher).

Days Inventory Outstanding

75.29

YoY

44.74%

Last updated:

Days Inventory Outstanding (DIO) of STCube is 2025 75.29 . Days Inventory Outstanding (DIO) of STCube was 2024 52.02 . It decreases by 44.74% higher compared to the previous year.

The STCube Days Inventory Outstanding history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Days Inventory Outstanding
Date
Days Inventory Outstanding
Jan 1, 2018
8.44 KRW
Jan 1, 2019
14.72 KRW
Jan 1, 2020
20.26 KRW
Jan 1, 2021
23.33 KRW
Jan 1, 2022
25.03 KRW
Jan 1, 2023
33.96 KRW
Jan 1, 2024
52.02 KRW
Jan 1, 2025
75.29 KRW
The STCube Days Inventory Outstanding history
YEARDays Inventory OutstandingYoY
75.29+44.74%
52.02+53.19%
33.96+35.68%
25.03+7.30%
23.33+15.12%
20.26+37.69%
14.72+74.28%
8.44-68.06%
26.44+196.34%
8.92-30.21%
12.78-81.10%
67.64—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

STCube Stock analysis

What does STCube do? STCube Inc. generates revenue through its two business segments. The IT segment distributes CCTV lenses and related components, targeting businesses requiring security solutions. The BT segment develops and licenses immunomodulatory anticancer drug therapeutic candidates, selling to pharmaceutical companies and research institutions. Both segments operate under the company's brand, leveraging its IT and biotechnology expertise. The IT segment focuses on closed-circuit television lens distribution, serving commercial and industrial clients seeking reliable security infrastructure. The BT segment's drug development and licensing activities cater to the pharmaceutical industry, providing innovative therapeutic candidates for cancer treatment. These offerings align with STCube's dual expertise in technology and biotechnology. STCube's revenue streams are derived from product distribution in the IT sector and licensing agreements in the biotechnology sector. The company's clients include businesses needing CCTV components and pharmaceutical firms interested in anticancer drug development. This dual approach allows STCube to serve distinct market segments with specialized solutions. STCube is one of the most popular companies on Eulerpool.

Frequently Asked Questions about STCube stock

Days Inventory Outstanding (DIO) of STCube is 75.29 in 2025.

Days Inventory Outstanding (DIO) of STCube changed from 52.02 to 75.29, representing a 44.74% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Days Inventory Outstanding (DIO) STCube since 2006 – with annual values, charts, and detailed analysis.

DIO measures the average number of days inventory is held before being sold. Lower values indicate more efficient inventory management.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Days Inventory Outstanding (DIO)'s STCube with sector peers and the industry average to assess whether it is attractive.

To evaluate Days Inventory Outstanding (DIO)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Days Inventory Outstanding (DIO).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — STCube

All Key Metrics — STCube